Compounds > n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and evans blue

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with evans blue in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azuma, M; Oka, T; Shearer, T	1
Ahn, DK; Bae, YC; Chae, JM; Choi, HS; Kwon, OW; Kyung, HM; Park, HS; Youn, DH	1

Other Studies

2 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and evans blue

Article	Year
Involvement of cyclooxygenase-2 in rat models of conjunctivitis. Current eye research, 2004, Volume: 29, Issue:1 Topics: Animals; Capillary Permeability; Carrageenan; Conjunctivitis; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Evans Blue; Gene Expression Regulation, Enzymologic; Immunoblotting; Immunoprecipitation; Isoenzymes; Lipopolysaccharides; Male; Membrane Proteins; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Up-Regulation	2004
Central cyclooxygenase inhibitors reduced IL-1beta-induced hyperalgesia in temporomandibular joint of freely moving rats. Pain, 2005, Volume: 117, Issue:1-2 Topics: Animals; Behavior, Animal; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Evans Blue; Formaldehyde; Hyperalgesia; Interleukin-1; Male; Nitrobenzenes; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Temporomandibular Joint Disorders; Time Factors; Wakefulness	2005

Article

Year

Involvement of cyclooxygenase-2 in rat models of conjunctivitis.

Current eye research, 2004, Volume: 29, Issue:1

Topics: Animals; Capillary Permeability; Carrageenan; Conjunctivitis; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Evans Blue; Gene Expression Regulation, Enzymologic; Immunoblotting; Immunoprecipitation; Isoenzymes; Lipopolysaccharides; Male; Membrane Proteins; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Up-Regulation

2004

Central cyclooxygenase inhibitors reduced IL-1beta-induced hyperalgesia in temporomandibular joint of freely moving rats.

Pain, 2005, Volume: 117, Issue:1-2

Topics: Animals; Behavior, Animal; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Evans Blue; Formaldehyde; Hyperalgesia; Interleukin-1; Male; Nitrobenzenes; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Temporomandibular Joint Disorders; Time Factors; Wakefulness

2005